Table 1.
Characteristics of patients with MPMs.
| Patient | Sex | Year of kidney transplant | Patient's age at transplant | Immunosuppressive drugs used | Acute rejection events | Type of first tumor | Date of first tumor | Type of second tumor | Date of second tumor | Return to dialysis (year) | Status (last follow-up) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M | 1995 | 39 | CCS + CyA + Myc | No | BCC | 2001 | Melanoma | 2006 | No | Alive (2012) |
| 2 | M | 1987 | 25 | CCS + CyA | No | SCC | 2008 | SCC | 2008 | Yes (2010) | Alive (2012) |
| 3 | M | 2001 | 64 | CCS + CyA + Myc | No | BCC | 2006 | SCC | 2006 | Yes (2011) | Alive (2012) |
| 4 | M | 2003 | 62 | CCS + FK > > Rap + CCS |
No | Prostate Ca | 2010 | Kidney Ca | 2010 | No | Alive (2012) |
| 5 | M | 2001 | 55 | CCS + CyA + Myc | No | BCC | 2002 | SCC | 2002 | No | Alive (2010) |
| 6 | M | 1988 | 45 | CyA > Rap + CCS | No | Kaposi | 2004 | Gastric MALToma | 2005 | Yes (2006) | Dead (2006) |
| 7 | M | 2001 | 55 | CCS + FK + Myc | No | BCC | 2003 | SCC | 2003 | No | Alive (2012) |
| 8 | M | 1992 | 42 | CCS + CyA | No | SCC | 2005 | BCC + SCC | 2005 | No | Alive (2012) |
| 9 | M | 1997 | 39 | CyA + Aza | No | SCC | 2003 | Melanoma | 2012 | No | Alive (2012) |
| 10 | M | 1995 | 51 | CCS + CyA + Myc | No | BCC | 2005 | BCC + SCC | 2010/2011 | No | Alive (2012) |
| 11 | F | 2004 | 53 | CCS + CyA > > Rap + CCS |
No | Lung Ca | 2005 | SCC | 2006 | Yes (2007) | Dead (2007) |
| 12 | M | 1998 | 56 | CCS + CyA | No | SCC | 1999 | BCC | 2007 | No | Alive (2012) |
| 13 | M | 1992 | 18 | CCS + CyA + Myc | Yes | BCC | 2000 | SCC | 2000 | Yes (2008) | Alive (2012) |
| 14 | M | 2001 | 61 | CCS + Rap + Myc | No | SCC | 2006 | SCC | 2007 | No | Alive (2007) |
| 15 | M | 1989 | 29 | CyA + Aza > > Rap + CCS |
No | BCC | 2007 | SCC | 2007 | No | Alive (2012) |
| 16 | M | 2005 | 43 | CCS + CyA | No | Melanoma | 2008 | BCC | 2008 | No | Alive (2012) |
| 17 | M | 1999 | 59 | CCS + CyA + Myc | No | BCC | 2004 | SCC | 2004 | No | Alive (2011) |
| 18 | M | 1986 | 46 | CCS + CyA | No | SCC | 1997 | Melanoma | 2004 | Yes (2004) | Dead (2007) |
| 19 | M | 2000 | 35 | CCS + CyA + Myc | No | SCC | 2006 | BCC | 2012 | No | Alive (2012) |
| 20 | M | 1994 | 38 | CCS + CYA | No | SCC | 2000 | SCC | 2000 | Yes (2010) | Alive (2012) |
| 21 | F | 1999 | 56 | CCS + CYA | No | SCC | 2004 | BCC | 2004 | No | Alive (2012) |
| 22 | F | 1996 | 49 | FK + Aza > > FK |
No | BCC | 2001 | BCC | 2001 | No | Alive (2012) |
| 23 | F | 1987 | 56 | CCS + FK | No | BCC | 1998 | SCC | 2006 | Yes (2011) | Alive (2012) |
| 24 | M | 2005 | 60 | CCS + FK > > Rap > FK |
No | SCC | 2006 | Colon Ca | 2011 | Yes (2012) | Alive (2012) |
M: male; F: female.
CCS: corticosteroids; Aza: azathioprine; CyA: cyclosporine; FK: tacrolimus; Myc: mycophenolate and derivatives; Rap: rapamycin and derivatives.
>: switch to other drug(s).
Ca: carcinoma; SCC: squamous cell carcinoma; BCC: basal cell carcinoma; Kaposi: Kaposi sarcoma; MALToma: neoplasm of mucosa associated lymphoid tissue.